5121612025-07-012025-09-305121612025-09-305121612025-03-315121612025-04-012025-09-305121612025-07-012025-09-30in-capmkt:OtherExpenses1Member5121612025-07-012025-09-30in-capmkt:OtherExpenses2Member5121612025-07-012025-09-30in-capmkt:OtherExpenses3Member5121612025-07-012025-09-30in-capmkt:OtherExpenses4Member5121612025-07-012025-09-30in-capmkt:OtherExpenses5Member5121612025-07-012025-09-30in-capmkt:OtherExpenses6Member5121612025-07-012025-09-30in-capmkt:OtherExpenses7Member5121612025-07-012025-09-30in-capmkt:OtherExpenses8Member5121612025-07-012025-09-30in-capmkt:OtherExpenses9Member5121612025-04-012025-09-30in-capmkt:OtherExpenses1Member5121612025-04-012025-09-30in-capmkt:OtherExpenses2Member5121612025-04-012025-09-30in-capmkt:OtherExpenses3Member5121612025-04-012025-09-30in-capmkt:OtherExpenses4Member5121612025-04-012025-09-30in-capmkt:OtherExpenses5Member5121612025-04-012025-09-30in-capmkt:OtherExpenses6Member5121612025-04-012025-09-30in-capmkt:OtherExpenses7Member5121612025-04-012025-09-30in-capmkt:OtherExpenses8Member5121612025-04-012025-09-30in-capmkt:OtherExpenses9Memberiso4217:INRiso4217:INRxbrli:shares512161SECURKLOUDNOTLISTEDINE650K01021SECUREKLOUD TECHNOLOGIES LIMITEDMain BoardEquity2025-04-012026-03-312025-11-142025-11-07INRLakhsQuarterlySecond quarterSingle segmentInformation Technology Services2025-11-1411:00:002025-11-1412:50:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated33804100073413000411454000000375459000204220006244000152118000554243000-1427890000-14278900082400002196000104360000-1532250000000-153225000317000-152908000-78962000-74263000-78645000-742630001670530005-2.35-2.3500-2.35-2.351. The above consolidated financial results for the quarter and twelve months ended March 31, 2024, were reviewed by the audit committee and approved by the Board of Directors in its meeting held on May 30, 2024, in line with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The Statutory auditors of the Company have carried out an audit of the consolidated financial results and have issued an unmodified review opinion on the same in accordance with SEBI Circular No.CIR/CFD/CMD!/44/2019 dated March 29, 2019. The review report of the statutory auditors is being filed with the National Stock Exchange of India Limited ('NSE') and BSE Ltd ('BSE') and is also available on the Company's website. The Consolidated financial results have been prepared in accordance with applicable Indian Accounting Standards as prescribed under Section 133 of the Companies Act, 2013 read with Rule 3 of the Companies (Indian Accounting Standards) Rules 2015, as amended, from time to time. <BR> <BR> 2. The Company operates in a single segment, i.e., "Information and Technology Services" and hence, does not have any additional disclosures to be made under Ind AS 108 - Operating Segments. <BR> <BR> 3. On February 27, 2025, Healthcare Triangle, Inc. (the "Company") entered into securities purchase agreements with several institutional investors (the "Investors') for the private placement of 36,190,485 units (each a, "Unit'), with each Unit consisting of one share of the Company's common stock ("Common Stock") and one pre-funded warrant (a "Pre-Funded Warrant') to purchase one share of Common Stock, one Series A Warrant (a "Series A Warrant') to purchase one share of common stock and one Series B Warrant (a "Series B Warrant" and together with the Series A Warrant, the "Purchase Warrants') to purchase one shzre of Common Stock at an offering price of $0.42 per Unit (or $0.41999 per Unit in the case of Units that include pre-funded warrants), for gross proceeds of $15.2 million (excluding any related expenses and underwriting discounts). The voting interest of Mr Suresh Venkatachari, Chairman and CEO of SecureKloud Technologies Limited ("SecureKloud"), was 55.50% as of March 31, 2025. Further, on May 14, 2025, the Company filed a notice of effectiveness and issued up to 1,483,809,885 shares of common stock consequent to the conversion of Series A and Series B Warrants. On such issuance, the voting interest of Mr Suresh Venkatachari, decreased from 55.50% as of March 31, 2025, to 1.40% as of June 30, 2025. <BR> On August 1, 2025, the Company implemented a one-for-two-hundred-forty-nine (1:249) reverse stock split of all its issued and outstanding common shares. As a result of this corporate action, the voting interest of Mr. Suresh Venkatachari increased from 1.40% to 77.40%. Therefore, SecureKloud's Board is able to effectively control and direct the operations of the Company through Mr. Suresh Venkatachari. Accordingly, Healthcare Triangle, Inc. is consolidated into the financial statements of SecureKloud from Q2FY2026, in accordance with Ind AS 110 - Consolidated Financial Statements. <BR> <BR> 4. On June 16, 2025. Quantum Nexis, Inc, a 100% subsidiary of Healthcare Triangle, Inc announced the acquisitions of Niyama Healthcare, Inc and Ezovion Solutions for an aggregate consideration up to Five Million Seven Hundred Thousand Dollars ($5,700,000), payable $1,500,000 as upfront cash, $3,000,000 in common stocks and an earn-out of up to $1,200,000, payable in cash based on the achievement of certain agreed-upon financial targets during the first 12 months following the closing date. <BR> <BR> 5. The Company had presented consolidated results for the quarter ended June 30, 2025 without Healthcare Triangle, Inc. For the quarter ended September 30, 2025, the financial results have been consolidated including the results of operations of Healthcare Triangle, Inc in accordance with Ind AS 110. Accordingly, the results for the quarter ended June 30, 2025 have been restated on a consolidated basis to facilitate comparability. <BR> <BR> 6. The figures in the previous period financial results have been reclassified to confirm to the presentation of the current quarter financial results. These reclassifications have no effect on the previously reported net loss/profit.2025-04-012025-09-30UnauditedConsolidated674748000765590007513070000007240240003901100094970002732430001045775000-294468000-1394939000-168940700082400002235000104750000-16998820000000-1699882000317000-1699565000-876010000-823872000-875693000-8238720001670530005-26.21-26.2100-26.21-26.21Professional and Consultancy Charges15450000Travelling and conveyance7637000Rent4460000Fees, Rates and taxes585000Sales and Marketing Expenses61330000Cloud Hosting and Communication Charges22539000Payments to auditors67000Directors' Sitting Fees35000Miscellaneous expenses40015000Professional and Consultancy Charges55908000Travelling and conveyance13881000Rent8801000Fees, Rates and taxes2999000Sales and Marketing Expenses88484000Cloud Hosting and Communication Charges46297000Payments to auditors1283000Directors' Sitting Fees125000Miscellaneous expenses55465000276410000005058980000000006957000695700028770002950005436680000043340900015568800000168410006059380001167700041643000659258000001202926000230949000-269373000-38424000-823872000-86229600035678800000098760003666640002435900000039102300068026200075100039395100039470200054483300016197970004903700053650000016741990000020652220001202926000390110000-2367240000272900006870005792800001495120000009497000004453000-1031000913570000000-1447000000-619730000040976000-164843100000073590001394939000-2608510000000000001726100000000000000000000000-133195000-15045600000000000010649000003901100000-49660000-46096700018517000-442450000598138000155688000-317000-31700000317000317000